Results 241 to 250 of about 31,231,377 (293)

Cyclic azapeptide CD36 ligand attenuates cardiac injury and reduces long‐chain fatty acid accumulation after myocardial ischemia–reperfusion in mice

FEBS Open Bio, EarlyView.
In a murine model of myocardial ischemia and reperfusion (MI/R), the CD36 azapeptide ligand MPE‐298 reduces cardiac injury and transiently lowers left ventricular long‐chain fatty acids (LCFAs) accumulation 3 h after reperfusion, accompanied by a decrease of oxidative stress and inflammation‐associated genes' expression in the heart and adipose tissue.
Jade Gauvin, Naghme Radmannia, David N. Huynh, Liliane Ménard, Caroline Daneault, Maïté Veilleux, Ahsanullah Ahsanullah, André C. Carpentier, William D. Lubell, Matthieu Ruiz, Huy Ong, Sylvie Marleau, Simon‐Pierre Gravel   +12 more
wiley   +1 more source

Reply to Melhorn and Couillard: Baseline Membrane Thickness in Asthma: Where Type-2 Inflammation Meets Remodeling? [PDF]

Am J Respir Crit Care Med
Leung C, Fahy JV.
europepmc   +1 more source

Type 2 inflammation in COPD: is it just asthma? [PDF]

Breathe (Sheff)
Beech A, Higham A, Booth S, Tejwani V, Trinkmann F, Singh D.   +5 more
europepmc   +1 more source

Type 2 inflammation accelerates CD4⁺ T-cell senescence in asthma. [PDF]

J Zhejiang Univ Sci B
Liu H, Li Z, Sun Y, Aili A, Chang C.
europepmc   +1 more source

Targeting type-2 inflammation in pulmonary hypertension: lessons from a novel model. [PDF]

Am J Physiol Lung Cell Mol Physiol
Singh N, Oldham WM.
europepmc   +1 more source

Type 2 airway inflammation in COPD

European Respiratory Journal
Globally, nearly 400 million persons have COPD, and COPD is one of the leading causes of hospitalisation and mortality across the world. While it has been long-recognised that COPD is an inflammatory lung disease, dissimilar to asthma, type 2 inflammation was thought to play a minor role.
Francesca, Polverino, Don D, Sin
openaire   +3 more sources

Regulation of type 2 inflammation by type I interferons [PDF]

, 2016
Rhinovirus-induced asthma exacerbations are a major cause of morbidity and mortality in patients. Experimental clinical infection studies indicate rhinovirus augments type 2 inflammation in asthma. Additionally, asthmatic lung cells have impaired type I interferon production in response to rhinovirus stimulation. Evidence suggests co-regulation of type
Ching, Yee-Man
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Inflammation and type 2 diabetes

Diabetes & Metabolism, 2012
Low-grade inflammation is a common feature in subjects with type 2 diabetes (T2D). Heart disease, the metabolic syndrome and T2D all have in common the increased concentration of circulatory cytokines as a result of inflammation. Inflammatory cytokines are produced by different cell types and secreted into the circulation, where they regulate different
M C, Calle, M L, Fernandez
openaire   +2 more sources

The emerging role of type 2 inflammation in asthma

Expert Review of Clinical Immunology, 2020
Introduction: Bronchial asthma (BA) is a chronic airways inflammatory disease. Based on the biological mechanisms that underline the disease, asthma has been classified as type 2 or non-type 2 phenotype.Areas covered: An emerging role has been identified for group 2 innate lymphoid cells (ILC2s) able to produce the classical type 2 cytokines.
Andrea Matucci, Susanna Bormioli, Francesca Nencini, Enrico Maggi, Alessandra Vultaggio   +4 more
openaire   +2 more sources

Resolution of Inflammation in Type 2 Diabetes

, 2017
Type 2 diabetes, ERV-1 receptor, phagocytosis, chronic inflammation, resolution.
Freire, Marcelo
core   +3 more sources